Teva Pharmaceutical Industries Ltd (TEVA)

TEVA (NYSE:Drugs)
$53.62
pos +0.00
+0.00%
Today's Range: 53.01 - 54.15 | TEVA Avg Daily Volume: 3,809,400
Last Update: 10/24/14 - 4:02 PM EDT
Volume: 0
YTD Performance: 33.78%
Open: $0.00
Previous Close: $53.60
52 Week Range: $36.26 - $55.70
Oustanding Shares: 854,000,000
Market Cap: 45,774,400,000
6-Month Chart
TheStreet Ratings Grade for TEVA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 10 10 8
Moderate Buy 0 0 0 0
Hold 9 10 10 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1
Mean Rec. 1.90 2.00 2.00 2.22
Latest Dividend: 0.29
Latest Dividend Yield: 2.33%
Dividend Ex-Date: 08/19/14
Price Earnings Ratio: 33.46
Price Earnings Comparisons:
TEVA Sector Avg. S&P 500
33.46 17.70 28.06
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.43% 32.99% 35.64%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.00 0.26 0.08
Net Income -34.40 -0.62 -0.28
EPS -33.60 -0.60 -0.26
Earnings for TEVA:
EBITDA 5.60B
Revenue 20.31B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.23 $1.28 $4.97 $4.89
Number of Analysts 10 9 14 14
High Estimate $1.29 $1.34 $5.08 $5.25
Low Estimate $1.15 $1.23 $4.82 $4.29
Prior Year $1.27 $1.42 $5.01 $4.97
Growth Rate (Year over Year) -2.91% -10.02% -0.90% -1.58%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

David Katz

 | Oct 21, 2014 | 12:30 PM EDT

Investing during a mid-term election can offer large returns.

bullishTeva Pharmaceuticals estimates, price target raised at UBS

Aug 4, 2014 | 7:56 AM EDT

TEVA price target raised from $50 to $54, UBS said. Neutral rating. Estimate also raised due to higher base sales.

By

Scott Redler

 | Jul 24, 2014 | 7:37 PM EDT

We raised our stops on Teva and added Staples to the long ideas table.

By

David Katz

 | Jul 11, 2014 | 7:30 AM EDT

It is preserving its Copaxone franchise, and the executive changes are good news.

By

Bret Jensen

 | Jun 18, 2014 | 10:19 AM EDT
In a flattish market, transports are strong on FedEx's earnings, and small-caps are underperforming.
By

Robert Moreno

 | May 12, 2014 | 1:16 PM EDT

Conflicting technical patterns suggest one is healthy and the other could be under the weather.

By

Ed Ponsi

 | Apr 15, 2014 | 12:00 PM EDT

 Stocks with good fundamentals are getting some respect.

By

Bret Jensen

 | Apr 8, 2014 | 9:00 AM EDT

A pullback of at least 10%, seems like a distinct possibility.

bullishTeva added to US Focus List at Citi

Mar 28, 2014 | 8:15 AM EDT

TEVA was placed on the US Focus List, Citigroup said. $60 price target. Company offers the bst risk/reward of the group.

bullishTeva upgraded at Goldman

Mar 19, 2014 | 8:25 AM EDT

TEVA was upgraded from Sell to Neutral, Goldman Sachs said. Copaxone slowdown is largely priced in and the underlying business can deliver growth. $52 price target. 

GS has cleared the important hurdle on the way up which increases the odds for an eventual...
A good quarterly report has sent shares of Calamos Asset Management (CLMS) sharply higher....
Electronics distributor Ingram Micro (IM) reported better than 16% growth in its Q3 sendin...
Market posting decent day considering Ebola getting headlines again. Believe investors ha...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.